- Home
- SOND vs CODX Comparison
SOND vs CODX Comparison
Compare SOND & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- CODX
- Stock Information
- Founded
- SOND 2014
- CODX 2013
- Country
- SOND United States
- CODX United States
- Employees
- SOND N/A
- CODX N/A
- Industry
- SOND Hotels/Resorts
- CODX Medical/Dental Instruments
- Sector
- SOND Consumer Discretionary
- CODX Health Care
- Exchange
- SOND Nasdaq
- CODX Nasdaq
- Market Cap
- SOND 17.2M
- CODX 16.9M
- IPO Year
- SOND N/A
- CODX 2017
- Fundamental
- Price
- SOND $1.21
- CODX $0.37
- Analyst Decision
- SOND
- CODX Buy
- Analyst Count
- SOND 0
- CODX 2
- Target Price
- SOND N/A
- CODX $2.00
- AVG Volume (30 Days)
- SOND 64.7K
- CODX 14.5M
- Earning Date
- SOND 11-03-2025
- CODX 11-06-2025
- Dividend Yield
- SOND N/A
- CODX N/A
- EPS Growth
- SOND N/A
- CODX N/A
- EPS
- SOND N/A
- CODX N/A
- Revenue
- SOND $606,649,000.00
- CODX $1,003,653.00
- Revenue This Year
- SOND $46.47
- CODX N/A
- Revenue Next Year
- SOND N/A
- CODX $31.58
- P/E Ratio
- SOND N/A
- CODX N/A
- Revenue Growth
- SOND N/A
- CODX N/A
- 52 Week Low
- SOND $1.21
- CODX $0.23
- 52 Week High
- SOND $4.99
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- SOND 29.63
- CODX 49.56
- Support Level
- SOND $1.21
- CODX $0.32
- Resistance Level
- SOND $1.37
- CODX $0.41
- Average True Range (ATR)
- SOND 0.13
- CODX 0.04
- MACD
- SOND -0.02
- CODX -0.01
- Stochastic Oscillator
- SOND 1.66
- CODX 27.33
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.